Document is current
Any future updates will be listed below
-
Authors
Xie, Connie T. Y.
Martinez, Samantha
Simon, Ceylon V.
Poutanen, Susan M.
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 3 March 2025
First Online: 5 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: Susan Poutanen reports a relationship with Merck & Co Inc and bioMérieux Inc that includes: consulting or advisory and speaking and lecture fees. Susan Poutanen reports a relationship with Endo Pharmaceuticals Inc, Pfizer Inc, Xediton, and Ferring Pharmaceuticals Inc that includes: consulting or advisory. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: Using a hospital-wide all-specimens antibiogram may both overcall and under call susceptibility leading to poor empiric antimicrobial choices. There is value-added to providing combined unit-specific and specimen-specific antibiograms to help best inform empiric therapy for specific populations.
